Indivior Pharmaceuticals Inc (INDV) key performance indicators and operating metrics (10 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Total Sublocade net revenue | 232M | FY2026-Q1 |
| Non-GAAP diluted earnings per share | 0.96 USD_per_share | FY2026-Q1 |
| Adjusted net income | 123M | FY2026-Q1 |
| Rest of world net revenue | 45M | FY2026-Q1 |
| United States Sublocade net revenue | 218M | FY2026-Q1 |
| Non-GAAP operating expenses | 116M | FY2026-Q1 |
| United States net revenue | 272M | FY2026-Q1 |
| Adjusted earnings before interest, taxes, depreciation, and amortization | 164M | FY2026-Q1 |
| United States Sublocade dispense unit volume growth year over year | 12.00 percent | FY2025-Q4 |
| Adjusted gross margin | 84.00 percent | FY2025-Q3 |
Back to INDV overview · INDV earnings · INDV holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.